Found 0 matching trials
Pyronaridine-artesunate With Low Dose Primaquine for Preventing P. Falciparum Transmission
PHASE2The purpose of this study is to assess the gametocytocidal and transmission...
Location
Malaria Research and Training Centre
Cohort Event Monitoring Study of Pyramax®
PHASE4The study is to be performed in public health facilities in Central and Wes...
Location
The Biotechnology Center Nkolbisson, Univ of Yaounde I, Messa
Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric Malaria
PHASE3The purpose of this study is to determine the efficacy of pyronaridine-arte...
Location
St. Jude's Clinic, ICIPE
Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients
PHASE3The primary objective of this Phase III clinical study is to demonstrate th...
Location
Centre National de Recherche et de Formation sur le Paludisme
Pharmacokinetic Study of Primaquine and Pyronaridine-Artesunate in Healthy Subjects
PHASE1The observed changes of P. falciparum sensitivity to artemisinin lead to th...
Location
Hospital of Tropical Diseases, Faculty of Tropical Medicine, Mahidol University
Safety of Antimalarials in the FIRst trimEster
PHASE3The SAFIRE study aims to find effective treatments with acceptable safety f...
Location
Clinical Research Unit of Nanoro (CRUN), Institut de Recherche en Sciences de la Santé, Direction Régionale de l'Ouest (IRSS-DRO)
The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3)
PHASE3This study is a multi-center, randomized, double-blind, parallel, placebo-c...
Location
Instituto Medico Platense
Phase II Dose-ranging Study of Pyronaridine/Artesunate in Adults Patients With Plasmodium Falciparum Malaria
PHASE2The primary trial objective is to determine the clinically effective dose o...
Location
Pailin General Hospital
Bioequivalence Trial of Pyronaridine Artesunate To-be-marketed Tablet to the Clinical Trial Reference Tablet
PHASE1The primary objective of this study is to determine the bioequivalence of t...
Location
Cross Research S.A., Phase I Unit
Pyramax in Asymptomatic Carriers of P. Falciparum Monoinfections
PHASE2This study will assess the efficacy of Pyramax administered for three-day, ...
Location
MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine,